NASA Logo
Human Research Roadmap
HRP
Exploration
Data
Home
|
HRP Goals and Objectives
|
Human Research Roadmap
|
HRP Organizational Structure
|
Acronyms
|
Reviews
|
Help
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
Evidence
Risks
Gaps
Tasks
Reports
Explore
Search
MICRO-01: We need to determine the efficacy of current countermeasures and the need for countermeasure development based on changes in microbial populations and characteristics. (Previous title: AEH 10)
This Gap was split into the following Gaps:
Micro-202: Evaluate the contribution of changes in microbial numbers, types, and virulence on the likelihood and consequence of non-infection-based effects on health and performance, including: decrease in cognition/mood/performance/blood-brain barrier (BBB) function related to the change in the gut’s microbiome and gut-brain axis, increase in cardiovascular health risks, effects of change in gut microbiome on metabolism of nutrients, and correlation with inflammation.
Micro-401: Test, optimize and validate existing terrestrial or novel technologies that can maintain in-flight microbial counts, types, and virulence at terrestrial equivalent levels.
Split Rationale
No rationale available.
Next
Previous
This gap can be found in the following Paths to Risk Reduction.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
NASA
Developer: Daniel Febus
Responsible NASA Official: Susan Torney
Contact HRP for a 508 compliant PDF
Budgets, Strategic Plans, and Accountability Reports
Equal Employment Opportunity Data Posted Pursuant to the No Fear Act
Information-Dissemination Policies and Inventories
Freedom of Information Act
President's Management Agenda
Privacy Policy & Important Notices
Inspector General Hotline
Contact HRP
Human Health and Performance DIR
Johnson Space Center
USA.gov
ExpectMore.gov